Decreased Risk of Osteoporosis Incident in Subjects Receiving Chinese Herbal Medicine for Sjögren syndrome Treatment: A Retrospective Cohort Study with a Nested Case-Control Analysis
Open Access
- 6 June 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (6) , 745
Abstract
Sjögren syndrome (SS) is a long-lasting inflammatory autoimmune disease that may cause diverse manifestations, particularly osteoporosis. Though usage of Chinese herbal medicine (CHM) can safely manage autoimmune disease and treatment-related symptoms, the relation between CHM use and osteoporosis risk in SS persons is not yet recognized. With that in mind, this population-level nested case-control study aimed to compare the risk of osteoporosis with and without CHM use. Potential subjects aged 20–70 years, diagnosed with SS between 2001 and 2010, were retrieved from a national health claims database. Those diagnosed with osteoporosis after SS were identified and randomly matched to those without osteoporosis. We capitalize on the conditional logistic regression to estimate osteoporosis risk following CHM use. A total of 1240 osteoporosis cases were detected and randomly matched to 1240 controls at a ratio of 1:1. Those receiving conventional care plus CHM had a substantially lower chance of osteoporosis than those without CHM. Prolonged use of CHM, especially for one year or more, markedly dwindled sequent osteoporosis risk by 71%. Integrating CHM into standard care may favor the improvement of bone function, but further well-designed randomized controlled trials to investigate the possible mechanism are needed.Keywords
This publication has 36 references indexed in Scilit:
- Epidemiology of Sjögren’s: A Systematic Literature ReviewRheumatology and Therapy, 2023
- Primary Sjogren syndrome increases the risk of bisphosphonate-related osteonecrosis of the jawScientific Reports, 2021
- Functions of estrogen and estrogen receptor signaling on skeletal muscleThe Journal of Steroid Biochemistry and Molecular Biology, 2019
- Ferulic acid, a dietary polyphenol suppresses osteoclast differentiation and bone erosion via the inhibition of RANKL dependent NF-κB signalling pathwayLife Sciences, 2018
- Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancerCancer Letters, 2013
- Puerarin inhibits iNOS, COX-2 and CRP expression via suppression of NF-κB activation in LPS-induced RAW264.7 macrophage cellsPharmacological Reports, 2011
- Changes in circulating cytokine levels in midlife women with psychological symptoms with selective serotonin reuptake inhibitor and Japanese traditional medicineMaturitas, 2009
- A critical appraisal of propensity‐score matching in the medical literature between 1996 and 2003Statistics in Medicine, 2007
- The components of excess mortality after hip fractureBone, 2003
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992